Intero Biosystems Inc.
Publicly observedAurora, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Aurora | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Intero Biosystems Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | CTNPP6BWF453 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant15 Jul 2026Publicly observed
NIH SBIR/STTR award: A Novel Human Intestinal Organoid Platform with Peristaltic Function for Drug Discovery and Pre-Clinical Testing in GI Motility Disorders
USD 349,824.00 · National Center for Advancing Translational Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jul 2026Publicly observed
NIH SBIR/STTR award: A Novel Multi-Lineage Human Intestinal Organoid Screening Platform for Drug Discovery and Preclinical Testing
USD 1,046,897.00 · National Center for Advancing Translational Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant20 Jun 2025Publicly observed
NIH SBIR/STTR award: A Novel Multi-Lineage Human Intestinal Organoid Screening Platform for Drug Discovery and Preclinical Testing
USD 349,952.00 · National Center for Advancing Translational Sciences · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.